Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Despite initial pharmaceutical interest, AOD 9604 did not progress through the full clinical trial pathway required for regulatory approval, and it holds no Marketing Authorisation (MA) from the MHRA or EMA
Things to Consider: Results may vary
Patients should be counseled never to administer extra doses to make up for missed doses, as this could increase the risk of adverse effects without providing additional therapeutic benefit
Rotating sites and injecting slowly often reduce symptoms
The rate of infusion is set to give the dose over 30 minutes to 1 hour
US$ 27.41
US$ 21.74
US$ 29.76
US$ 26.46
US$ 24.86
